Secukinumab is effective and safe in the long-term treatment of plaque psoriasis in a daily practice setting: Multicenter study in 384 Spanish patients

Chicharro, P; Llamas-Velasco, M; Armesto, S; Acosta, EH; Vidal, D; Vilarrasa, E; Rivera-Diaz, R; De-la-Cueva, P; Martorell-Calatayud, A; Ballesca, F; Belinchon, I; Carretero, G; Rodriguez, L; Romero-Mate, A; Pujol-Montcusi, J; Salgado, L; Sahuquillo-Torralba, A; Coto-Segura, P; Rodriguez, OB; Feltes, R; Riera-Monroig, J; Dauden, E – 2022